In this episode of Believe in Progress, cancer survivor and retired senior partner at McKinsey & Company Larry Kanarek talks about his career in consulting and how cancer shaped his views on accelerating progress in cancer research.
Listen and SubscribeThe AACR shared the results of a recent national survey demonstrating that Americans support federal funding for cancer research by an overwhelming margin.
Learn MoreUnifying Cancer Science and Medicine: A Continuum of Innovation for Impact. The report highlights research-driven advances against the collection of devastating diseases we call cancer.
Read the ReportMore than 80,000 people in the U.S. are expected to be diagnosed with non-Hodgkin lymphoma this year. September is Leukemia and Lymphoma Awareness Month.
Learn MoreBoosting the Immune Response to Cancer: Decades of pioneering research led to a first-of-its-kind FDA approval for a new type of immunotherapy—tumor-infiltrating lymphocyte (TIL) therapy.
Learn MoreRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowOn-demand access to session recordings is available to registrants through Friday, October 31.
The AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Siu, AACR President 2025-2026, discusses the importance of collaboration to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More